K2 HealthVentures Equity Trust LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA)

Filing Manager
K2 HealthVentures Equity Trust LLC
Reporting Manager
K2 HealthVentures Equity Trust LLC
Security
Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
NMRA
Shares outstanding
179,581,537 shares
Disclosed Ownership
8,997,035 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:41:48 UTC
Date of event
31 Dec 2025
Previous filing
11 Aug 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"K2 HealthVentures Equity Trust LLC disclosed 5% ownership in Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA) on 31 Dec 2025."

Quick Takeaways

  • K2 HealthVentures Equity Trust LLC filed SCHEDULE 13G/A for Neumora Therapeutics, Inc. Common Stock, par value $0.0001 per share (NMRA).
  • Disclosed ownership: 5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 11 Aug 2025.
  • Current filing was accepted on 17 Feb 2026, 16:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
K2 HealthVentures Equity Trust LLC 5% 8,997,035 0 8,997,035 /s/ Anup Arora Anup Arora, Managing Member
Parag Shah 5% 8,997,035 0 8,997,035 /s/ Parag Shah Parag Shah
Anup Arora 5% 8,997,035 0 8,997,035 /s/ Anup Arora Anup Arora

Sponsored